الصفحة الرئيسية>>Lipids>>Ionizable Lipid 4

Ionizable Lipid 4

رقم الكتالوجGC91552

Ionizable lipid 4 is an ionizable cationic lipid (pKa = 6.1) and a hydrogen peroxide-induced rearrangement product of the cationic lipid CA-lipid 5.

Products are for research use only. Not for human use. We do not sell to patients.

Ionizable Lipid 4 التركيب الكيميائي

Cas No.: 1799316-81-6

الحجم السعر المخزون الكميّة
5 mg
139٫00
متوفر
10 mg
249٫00
متوفر
25 mg
589٫00
متوفر
50 mg
1040٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Ionizable lipid 4 is an ionizable cationic lipid (pKa = 6.1) and a hydrogen peroxide-induced rearrangement product of the cationic lipid CA-lipid 5.[1] Charge-altering lipid nanoparticles (CALNPs) containing CA-lipid 5 and encapsulating siRNA against EGFP undergo hydrogen peroxide-induced removal of the phenylboronic acid groups from CA-lipid 5 in MCF-7 cells in vitro, generating ionizable lipid 4-containing LNPs with reduced positive charges at physiological pH, facilitating intracellular siRNA release and gene silencing. LNPs containing ionizable lipid 4 and encapsulating siRNA against PLK1 reduce tumor volume in an MCF-7 mouse xenograft model less effectively than CALNPs containing CA-lipid 5.

References:
[1].Yang, F., Lei, L., Wang, X., et al.Engineering cell-selective charge-altering lipid nanoparticles for efficient siRNA delivery in vivoCCS ChemistryOnline ahead of print(2024).

مراجعات

Review for Ionizable Lipid 4

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Ionizable Lipid 4

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.